Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Accidental nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Intentional nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Nitrate poisoning of undetermined intent |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Nitrate vasodilator adverse reaction |
Causative agent (attribute) |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Parenteral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Oral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate adverse reaction |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide mononitrate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Nitrate vasodilator allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergie au dinitrate d'isosorbide |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Parenteral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Oral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergie au mononitrate d'isosorbide |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide mononitrate allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Nitrate overdose |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate overdose (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate overdose |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 25mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 50mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 25mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate+aspirin 60mg/150mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate+aspirin 60mg/75mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 500 microgrammes/mL, fiole de 50 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 30mg transdermal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 1 mg/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 1 mg/mL, fiole de 50 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Nitrate-based vasodilating agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide mononitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Transdermal isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Pentaerithrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Glyceryl trinitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Poisoning by nitrate |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Inositol hexanitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Eritrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Amyl nitrite (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Methemoglobinemia due to nitrate poisoning (disorder) |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Amyl nitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Inositol nicotinate 200 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing inositol niacinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Accidental nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Intentional nitrate poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Poisoning caused by nitrate vasodilator |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Nitrate vasodilator allergy |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Nitrate vasodilator overdose |
Causative agent (attribute) |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Accidental nitrate vasodilator poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Intentional nitrate vasodilator poisoning |
Causative agent (attribute) |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |